Patient-reported outcomes (PROs) from DeLLphi-304: The first phase III trial evaluating tarlatamab and chemotherapy (CTx) in patients (Pts) with previously treated small cell lung cancer (SCLC)
  • Mountzios, G.
  • Sun, L.
  • Cho, B. C.
  • Demirci, U.
  • Baka, S.
  • 외 15명
Citations

WEB OF SCIENCE

0
제목
Patient-reported outcomes (PROs) from DeLLphi-304: The first phase III trial evaluating tarlatamab and chemotherapy (CTx) in patients (Pts) with previously treated small cell lung cancer (SCLC)
저자
Mountzios, G.Sun, L.Cho, B. C.Demirci, U.Baka, S.Gumus, M.Lugini, A.Zhu, B.Yu, Y.Ciuleanu, T. E.Ahn, M. J.da Rocha, P. F. SimoesMazieres, J.Schuler, M. H. H.Blackhall, F.Yoshida, T.Jiang, T.Dirnberger, F.Wang, J.Rudin, C. M.
DOI
10.1016/j.annonc.2025.08.3384
발행일
2025-09
유형
Meeting Abstract
저널명
Annals of Oncology
36